Related Experiment Videos

Prefrontal cortex cognitive deficits in children treated early and continuously for PKU

A Diamond1, M B Prevor, G Callender

  • 1Center for Developmental Cognitive Neuroscience, Eunice Kennedy Shriver Center, Waltham, Massachusetts, USA.

Insights

Phenylketonuria (PKU) children with high phenylalanine levels show impaired executive functions, particularly working memory and inhibitory control, due to reduced dopamine in the prefrontal cortex. This deficit is evident early and affects girls more than boys.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Biochemistry

Background:

  • Phenylketonuria (PKU) is a metabolic disorder causing elevated phenylalanine (Phe) and reduced tyrosine (Tyr), the dopamine precursor.
  • Dopamine is crucial for prefrontal cortex functions, including executive functions.
  • Early and continuous PKU treatment reduces but does not eliminate the Phe:Tyr imbalance.

Purpose of the Study:

  • To investigate the impact of dopamine reduction in the prefrontal cortex on executive functions in early childhood.
  • To examine the relationship between phenylalanine levels and cognitive performance in children with PKU.

Main Methods:

  • A 4-year longitudinal study of children with PKU and matched controls.
  • Assessment of working memory and inhibitory control abilities dependent on the dorsolateral prefrontal cortex.
  • Correlation of plasma phenylalanine levels with cognitive task performance.

Main Results:

  • PKU children with Phe levels 3-5 times normal performed significantly worse on executive function tasks than controls, siblings, and general population children.
  • The cognitive impairment was consistent across age ranges (6 months to 7 years).
  • Higher Phe levels correlated with poorer performance; girls were more adversely affected than boys.

Conclusions:

  • Reduced prefrontal cortex dopamine, secondary to PKU, selectively impairs executive functions in early childhood.
  • The findings highlight the critical role of dopamine in developing cognitive abilities.
  • Clinical implications exist for managing PKU and other neurodevelopmental disorders affecting dopamine pathways.

Related Concept Videos